Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: In this study we sought to identify differences in risk factors and outcome of critically ill patients with Candida albicans and non-albicans candidemia. METHODS: Nonimmunosuppressed, nonneutropenic patients with candidemia diagnosed after intensive care unit (ICU) admission were included in a prospective observational study in a medical-surgical ICU at a tertiary academic hospital in Athens, Greece. RESULTS: During the study period (January 2001 to December 2005), 56 candidemia episodes in 1037 ICU admissions were included (5.4%). Of these patients, 36/56 (64.3%) had candidemia due to C. albicans and 20/56 (35.7%) due to non-albicans species (8/56 [14.3%] C. glabrata, 6/56 [10.7%] C. tropicalis, 3/56 [5.4%] C. parapsilosis, 1/56 [1.8%] C. lusitaniae, 1/56 [1.8%] C. krusei and 1/56 [1.8%] C. dubliniensis). Administration of glucocorticosteroids, central venous catheter placement, and preexisting candiduria were independently associated with candidemia due to C. non-albicans species (Odds ratio [OR]: 45.1, 95% confidence interval [CI]: 3.0-669.9; OR: 26.2, 95% CI: 2.1-334.8; and OR: 16.5, 95% CI: 1.6-173.9, respectively). The treatment response rate differed significantly between patients with C. albicans and patients with C. non-albicans bloodstream infections (29/36 [80.6%] vs 9/20 [45%], P = 0.006). Overall mortality was higher in patients with non-albicans species than C. albicans bloodstream infections (18/20 [90%] vs 19/36 [52.8%], P = 0.005). Multivariable logistic regression analysis revealed that candidemia due to non-albicans species was independently associated with death (OR: 6.7, 95% CI: 1.2-37.7). CONCLUSIONS: In the subset of critically ill nonimmunosuppressed patients, candidemia caused by non-albicans species occurred more frequently in those with medical devices or receiving steroids. Candidemia due to non-albicans species was also associated with higher mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These species exhibit higher levels of resistance to antifungal medications and might be associated with higher mortality than C. albicans (18).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [18]
In the citing paper
“Compared with C. albicans, these species more frequently exhibit antifungal resistance and might be associated with higher mortality rates for patients with candidemia (12–14).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — 10 Sites, United States, 2017–2021 (2025) · cites this paper as [12]
In the citing paper
“a prospective study in a medical-surgical ICU suggested that candidemia due to non-albicans species was associated with higher mortality [16].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [16]
Citations
Cites
Nosocomial infections in medical intensive care units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., & Gaynes, R. P. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00020 · Cited by 1,565
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376906 · Cited by 845
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
Krcmery, V., & Barnes, A. J. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1151 · Cited by 733 · cited 2×
“albicans, varying from 15% to 35%.(11) However, there are very few”
BackgroundTrick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Tortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1103-y · Cited by 509
Epidemiological trends in nosocomial candidemia in intensive care
Bassetti, M., Righi, E., Costa, A., Fasce, R., Molinari, M. P., Rosso, R., Pallavicini, F. B., & Viscoli, C. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-21 · Cited by 332
Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies
Falagas, M. E., Apostolou, K. E., & Pappas, V. D. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0159-2 · Cited by 294
Self-citationPfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Hollis, R. J., Messer, S. A., & Group, F. T. S. P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.7.1886-1889.1998 · Cited by 281
Viudes, A., Pemán, J., Cantón, E., Úbeda, P., López-Ribot, J., & Gobernado, M. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0822-1 · Cited by 250
Cited by
Epidemiology and risk factors for invasive candidiasis
Yapar, N. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s40160 · Cited by 610
“A study conducted between 2001 and 2005 in Greece identified glucocorticoid use, presence of central venous catheters, and candiduria as independent risk factors for infections due to non-albicans species.(30) A similar study conducted in the USA between 1995 and 2005 reported that the duration of fluconazole treatmen…”
Background-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538
“dependent on various types of supportive care [4, 5].”
BackgroundSelf-citationInfection Risk and Safety of Corticosteroid Use
Youssef, J., Novosad, S. A., & Winthrop, K. L. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.004 · Cited by 459
Antifungal drug resistance among Candida species: mechanisms and clinical impact
Sanguinetti, M., Posteraro, B., & Lass‐Flörl, C. (2015) · Mycoses · doi:10.1111/myc.12330 · Cited by 394
Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis
Koehler, P., Stecher, M., Cornely, O. A., Koehler, D., Vehreschild, M. J. G. T., Bohlius, J., Wisplinghoff, H., & Vehreschild, J. J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.024 · Cited by 336
Dadar, M., Tiwari, R., Karthik, K., Chakraborty, S., Shahali, Y., & Dhama, K. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.02.028 · Cited by 332
Rajendran, R., Sherry, L., Nile, C. J., Sherriff, A., Johnson, E. M., Hanson, M. F., Williams, C., Munro, C. A., Jones, B. J., & Ramage, G. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.09.018 · Cited by 228
“The difference could be explained by an increasing population and by inaccurate reporting of the cases, and is therefore likely to represent a minimum estimate of the incidence of Candida BSI in Scotland.”
BackgroundInfluentialEpidemiology of candidemia in intensive care units
Bouza, E., & Muñoz, P. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70006-2 · Cited by 207
“albicans bloodstream infections [16].”
BackgroundToda, M., Williams, S. R., Berkow, E. L., Farley, M. M., Harrison, L. H., Bonner, L., Marceaux, K. M., Hollick, R., Zhang, A. Y., Schaffner, W., et al. (2019) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6808a1 · Cited by 198
“Total parenteral nutrition in the 14 days before candidemia diagnosis 506 (31) 182 (18) 58 (17) 87 (17) 833 (24)”
BackgroundInfluentialMontagna, M. T., Caggiano, G., Lovero, G., De Giglio, O., Coretti, C., Cuna, T., Iatta, R., Giglio, M., Dalfino, L., Bruno, F., et al. (2013) · Infection · doi:10.1007/s15010-013-0432-0 · Cited by 185
“In agreement with other studies [2, 31], we observed an association between ICU LOS, parenteral nutrition, and C.”
ResultInvasive Fungal Infections in the ICU: How to Approach, How to Treat
Paramythiotou, E., Frantzeskaki, F., Flevari, A., Armaganidis, A., & Dimopoulos, G. (2014) · Molecules · doi:10.3390/molecules19011085 · Cited by 175
“In a case-comparator study Chow et al. showed that fluconazole exposure, presence of a central venous catheter and mean number of antibiotics per day were associated with an increased risk of BSIs due to NAS compared to C. albicans while in another study use of medical devices, steroids receipt and pre-existing candid…”
BackgroundInfluentialSelf-citationGuery, B. P., Arendrup, M. C., Auzinger, G., Azoulay, É., Borges Sá, M., Johnson, E. M., Müller, E., Putensen, C., Rotstein, C., Sganga, G., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-008-1338-7 · Cited by 173
“The increasing incidence of non-albicans Candida species could be important, as a prospective study in a medical–surgical ICU suggested that candidemia due to non-albicans species was associated with higher mortality [16].”
BackgroundInsights into Candida tropicalis nosocomial infections and virulence factors
Negri, M., Silva, S., Henriques, M., & Oliveira, R. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1455-z · Cited by 132
“extended periods in ICUs, administration of broadspectrum antibiotics, patients with immunosupression, indwelling catheters, mechanical ventilation, candiduria, multiple sites of colonization, burns, and hemodialysis [5, 52– 54].”
BackgroundRisk Factors for Fluconazole-Resistant Candidemia
Garnacho-Montero, J., Díaz-Martín, A., García-Cabrera, E., Ruiz Pérez de Pipaón, M., Hernández-Caballero, C., Aznar-Martín, J., Cisneros, J. M., & Ortiz-Leyba, C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00479-10 · Cited by 127
“(1, 9, 10, 23) or by potentially fluconazole-resistant organisms (Candida glabrata and Candida krusei) (16, 23, 28) but have not taken into consideration in vitro resistance to fluconazole.”
BackgroundInfluentialDrgona, L., Khachatryan, A., Stephens, J., Charbonneau, C., Kantecki, M., Haider, S., & Barnes, R. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1944-3 · Cited by 126
Grim, S. A., Berger, K., Teng, C., Gupta, S., Layden, J. E., Janda, W. M., & Clark, N. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr511 · Cited by 118
Prasath, K. G., Tharani, H., Kumar, M. S., & Pandian, S. K. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00864 · Cited by 127
Chi, H.-W., Yang, Y.-S., Shang, S.-T., Chen, K.-H., Yeh, K.-M., Chang, F.-Y., & Lin, J.-C. (2011) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2010.08.010 · Cited by 103
Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
Kaur, H., & Chakrabarti, A. (2017) · Journal of Fungi · doi:10.3390/jof3030041 · Cited by 93
“It is observed that the candidemia caused by NAC species has an independent association with the use of central venous catheter, glucocorticoids and presence of candiduria [58].”
BackgroundMontagna, M. T., Lovero, G., Borghi, E., Amato, G., Andreoni, S., Campion, L., Cascio, G. L., Lombardi, G., Luzzaro, F., Manso, E., et al. (2014) · PubMed · Cited by 103
Gómez-Gaviria, M., & Mora-Montes, H. M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s247944 · Cited by 109
Rajendran, R., Sherry, L., Deshpande, A., Johnson, E. M., Hanson, M. F., Williams, C., Munro, C. A., Jones, B. L., & Ramage, G. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00915 · Cited by 81
Spiering, M. J., Moran, G. P., Chauvel, M., MacCallum, D. M., Higgins, J., Hokamp, K., Yeomans, T., d'Enfert, C., Coleman, D. C., & Sullivan, D. J. (2010) · Eukaryotic Cell · doi:10.1128/ec.00291-09 · Cited by 77
“albicans, as judged by differences in carriage rates and prevalence in the human host (7, 27, 28, 45) and by differences in virulence in vitro and in murine infection models (8, 12, 23, 41).”
BackgroundCandida Non-albicans Versus Candida Albicans Fungemia in the Non-neonatal Pediatric Population
Dutta, A., & Palazzi, D. L. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318213da0f · Cited by 80
“NAC BSI has been independently associated with increased risk of mortality in the adult intensive care unit (ICU) patients.(14) The use of azoles and echinocandins as prophylactic antifungals has been implicated as a major cause for the increase in NAC BSI.”
BackgroundOccurrence, presentation and treatment of candidemia
Mikulska, M., Del Bono, V., Ratto, S., & Viscoli, C. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.52 · Cited by 71
Fungemia in COVID‐19 ICU patients, a single medical center experience
Bishburg, E., Okoh, A., Nagarakanti, S. R., Lindner, M., Migliore, C., & Patel, P. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26633 · Cited by 70
“3% respectively.(16,17) In our patients with candidemia, BMI at baseline was found to be higher, than a matched group of controls.”
BackgroundEvaluation of species distribution and risk factors of candidemia: A multicenter case-control study
Yapar, N., Pullukcu, H., Avkan-Oguz, V., Sayin-Kutlu, S., Ertugrul, B., Sacar, S., Cetin, B., & Kaya, O. (2011) · Medical Mycology · doi:10.3109/13693786.2010.501344 · Cited by 69
Holley, A., Dulhunty, J. M., Blot, S. I., Lipman, J., Lobo, S. M., Dancer, C., Rello, J., & Dimopoulos, G. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.035 · Cited by 81
Self-citationExperimental mouse models of disseminated Candida auris infection
Xin, H., Mohiuddin, F., Tran, J., Adams, A., & Eberle, K. (2019) · mSphere · doi:10.1128/msphere.00339-19 · Cited by 67
Candida dubliniensis: An Appraisal of Its Clinical Significance as a Bloodstream Pathogen
Khan, Z., Ahmad, S., Joseph, L., & Chandy, R. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032952 · Cited by 73
“isolates (Table S1) [6,10,24–42].”
van Hal, S. J., Marriott, D. J. E., Chen, S. C.-A., Nguyen, Q. A., Sorrell, T. C., Ellis, D. H., Slavin, M. A., & Study, T. A. C. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2009.00371.x · Cited by 65
Candidemia in the Intensive Care Unit
Epelbaum, O., & Chasan, R. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.04.010 · Cited by 78
Current diagnostic approaches to invasive candidiasis in critical care settings
Pemán, J., & Zaragoza, R. (2010) · Mycoses · doi:10.1111/j.1439-0507.2009.01732.x · Cited by 68
Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit
Bassetti, M., Mikulska, M., & Viscoli, C. (2010) · Critical Care · doi:10.1186/cc9239 · Cited by 57
“Numerous studies have tried to fi nd reasons for this shift, and several risk factors have been associated with candidemia due to diff erent species [25,34].”
BackgroundZhang, Z., Zhu, R., Luan, Z., & Ma, X. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-036452 · Cited by 65
Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species
Whibley, N., & Gaffen, S. L. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.025 · Cited by 77
Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study
Aguilar, G., Delgado, C., Corrales, I., Izquierdo, A. C., Gracia, E., Moreno, T., Romero, E., Ferrando, C., Carbonell, J., Borrás, R., et al. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1458-4 · Cited by 77
Invasive Fungal Infections in the ICU
Shoham, S., & Marwaha, S. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609355262 · Cited by 63
Hou, T.-Y., Wang, S.-H., Liang, S.-X., Jiang, W.-X., Luo, D.-D., & Huang, D.-H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131602 · Cited by 53
Fungal bloodstream infections in tertiary care hospitals in Colombia
Cortés, J. A., Reyes, P., Gómez, C., Buitrago, G., & Leal, A. L. (2011) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2010.12.002 · Cited by 58
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi, V., Schizodimos, T., & Kotoulas, S. (2021) · Infection · doi:10.1007/s15010-021-01640-7 · Cited by 59
Whibley, N., Jaycox, J. R., Reid, D. M., Garg, A. V., Taylor, J. A., Clancy, C. J., Nguyen, M. H., Biswas, P. S., McGeachy, M. J., Brown, G. D., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500870 · Cited by 54
Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients*
Cohen, Y., Karoubi, P., Adrie, C., Gauzit, R., Marsepoil, T., Zarka, D., & Clecʼh, C. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cc4734 · Cited by 48
“Previously published studies have attempted to identify risk factors for all nonalbicans species (15, 16).”
BackgroundDing, X., Yan, D., Sun, W., Zeng, Z., Su, R., & Su, J. (2015) · Medical Mycology · doi:10.1093/mmy/myv060 · Cited by 81
“The data that are available are mostly limited to special populations, such as cancer patients or critically ill patients from Western Countries [17,18] and have predominantly focused on single species, such as C. glabrata, C. parapsilosis, or C. krusei, rather than evaluating all NAC spp. together [19].”
BackgroundResultInfluentialSeptic Shock Due to Candidemia: Outcomes and Predictors of Shock Development
Guzman (2011) · Journal of Clinical Medicine Research · doi:10.4021/jocmr536w · Cited by 47
Sheth, C. C., Hall, R., Lewis, L., Brown, A. J. P., Odds, F. C., Erwig, L. P., & Gow, N. A. R. (2011) · Medical Mycology · doi:10.3109/13693786.2010.551425 · Cited by 45
Kim, E. J., Lee, E., Kwak, Y. G., Yoo, H. M., Choi, J. Y., Kim, S. R., Shin, M. J., Yoo, S.-Y., Cho, N.-H., & Choi, Y. H. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.606976 · Cited by 47
Jenkins, E. N., Gold, J. A. W., Benedict, K., Lockhart, S. R., Berkow, E. L., Dixon, T., Shack, S. L., Witt, L. S., Harrison, L. H., Seopaul, S., et al. (2025) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7404a1 · Cited by 43
“Compared with C. albicans , these species more frequently exhibit antifungal resistance and might be associated with higher mortality rates for patients with candidemia ( 12 – 14 ).”
Candidemia in the critically ill patient
Picazo, J. J., González‐Romo, F., & Candel, F. J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70005-0 · Cited by 50
“These factors may vary slightly depending on the Candida species involved [8].”
BackgroundMolecular assay to detect nosocomial fungal infections in intensive care units
Badiee, P., Alborzi, A., & Joukar, M. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.08.025 · Cited by 47
“4% of 1037 ICU admissions [26].”
Zaragoza, R., Perman, J., Salavert, M., Viudes, Solé, A., Jarque, I., Cantón, R., Monte‐Boquet, E., & Romá, E. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3994 · Cited by 46
“…are now caused by NCA species (Pfaller et al 2000; Tortorano et al 2004; Almirante et al 2005), and several publications have indicated that these cases have a worse prognosis than those caused by C. albicans (Ben Abraham et al 2004; Klingspor et al 2004; Morgan et al 2005; Dimopoulos et al 2008).”
Risk factors and outcomes of patients with ocular involvement of candidemia
Son, H., Kim, M. J., Lee, S., Choi, S., Jung, K. H., Jung, J., Chong, Y. P., Kim, S., Choi, S., Kim, Y. S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222356 · Cited by 41
Zhang, W., Song, X., Wu, H., & Zheng, R. (2019) · Epidemiology and Infection · doi:10.1017/s0950268819001638 · Cited by 56
“Several possible risk factors have been previously identified for the development of NAC candidaemia and include prior antifungal exposure, malignancy, immunosuppressive therapy, abdominal surgery [32], presence of CVCs [26], artificial surgical implants [17], head trauma and bacterial sepsis [29].”
BackgroundInfluentialKazak, E., Akın, H., Ener, B., Sığırlı, D., Özkan, Ö., Gürcüoğlu, E., Yılmaz, E., Çelebi, S., Akçağlar, S., & Akalın, H. (2014) · Mycoses · doi:10.1111/myc.12209 · Cited by 39
Singh, R., Xess, I., Mathur, P., Behera, B., Gupta, B., & Misra, M. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.023739-0 · Cited by 52
Fungal Infections: Their Diagnosis and Treatment in Transplant Recipients
Thiel, D. H. V., George, M., & Moore, C. M. (2012) · International Journal of Hepatology · doi:10.1155/2012/106923 · Cited by 39
“The early infections due to candidiasis are a result of the use of indwelling catheters, central lines, abdominal wounds, drains, and secondary operations as well as the use of parenteral nutrition and mechanical ventilation [5].”
How to treat fungal infections in ICU patients
Matthaiou, D. K., Christodoulopoulou, T. C., & Dimοpoulos, G. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0934-8 · Cited by 44
“Candida colonization is referred to as a risk factor for developing invasive candidiasis [13,14].”
BackgroundKourkoumpetis, T. K., Velmahos, G. C., Ziakas, P. D., Tampakakis, E., Manolakaki, D., Coleman, J. J., & Mylonakis, E. E. (2010) · Mycopathologia · doi:10.1007/s11046-010-9369-3 · Cited by 35
Liu, F., Zhong, L., Zhou, F., Zheng, C., Zhang, K., Cai, J., Zhou, H., Tang, K., Dong, Z., Cui, W., et al. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s323583 · Cited by 41
Alp, S., Arikan‐Akdagli, S., Gulmez, D., Ascioglu, S., Uzun, O., & Akova, M. (2015) · Mycoses · doi:10.1111/myc.12349 · Cited by 32
Jordán, I., Balaguer, M., López-Castilla, J.-D., Hofheinz, S. B., Schüffelmann, C., Teresa, M. A. G., Madurga, P., Flores-González, J. C., Anguita, P., & Aguilar, L. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000274 · Cited by 33
“com | e191 associated with infection by non-albicans species have also been described in adults, with steroid administration, central venous catheter and candiduria having been identified as independent risk factors for infection.(20,21) Extrapolation of results from adults or neonates to pediatric patients may not be…”
BackgroundINVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
Mikulska, M., Bassetti, M., Ratto, S., & Viscoli, C. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.007 · Cited by 37
How to select an antifungal agent in critically ill patients
Dimοpoulos, G., Antonopoulou, A., Armaganidis, A., & Vincent, J. (2013) · Journal of Critical Care · doi:10.1016/j.jcrc.2013.04.006 · Cited by 35
“Invasive fungal infections are increasingly common in intensive care unit (ICU) patients and are associated with prolonged duration of hospitalization and increased mortality [1-3].”
BackgroundSelf-citationMalpica, L., van Duin, D., & Moll, S. (2019) · American Journal of Hematology · doi:10.1002/ajh.25642 · Cited by 34
Candida Infections and Modelling Disease
MacCallum, D. M. (2009) · Springer eBooks · doi:10.1007/978-3-642-03150-2_3 · Cited by 32
Dimοpoulos, G., Velegraki, A., & Falagas, M. E. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01368-08 · Cited by 35
Self-citationDewan, E., Biswas, D., Kakati, B., Verma, S., Kotwal, A., & Oberoi, A. (2015) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2015.06.006 · Cited by 35
Coping with Candida Infections
Evans, S. E. (2010) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200907-075al · Cited by 32
“glabrata infections are often associated with recent surgery, the use of urinary or vascular catheters, solid tumors, and lymphoma (36, 37).”
BackgroundPanpetch, W., Phuengmaung, P., Hiengrach, P., Issara-Amphorn, J., Cheibchalard, T., Somboonna, N., Tumwasorn, S., & Leelahavanichkul, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137050 · Cited by 30
“However, Gram-negative bacteria are not the only gut organisms; gut fungi (especially Candida albicans) are the second most abundant organisms in the human gut that can also be a cause of nosocomial infection [11] with a high mortality rate [12].”
BackgroundPharmacotherapy of yeast infections
Gómez‐López, A., Zaragoza, Ó., Rodríguez-Tudela, J. L., & Cuenca‐Estrella, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.16.2801 · Cited by 36
“albicans species is associated with higher mortality [37] , so early initiation of appropriate antifungal therapy is essential for reducing the morbidity and mortality of these invasive fungal infections.”
BackgroundLin, K., Liu, Y.-M., Lin, P., Ho, C., Chou, C.-H., Wang, J.-H., Chi, C.-Y., Ho, M., & Wang, J.-H. (2012) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2012.08.010 · Cited by 28
Hu, B., Du, Z., Kang, Y., Zang, B., Cui, W., Qin, B., Fang, Q., Qiu, H., & Li, J. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0594-0 · Cited by 32
“This observation was consistent with previous studies on candidemia [6,25,33].”
BackgroundResultCorte, L., Roscini, L., Colabella, C., Tascini, C., Leonildi, A., Sozio, E., Menichetti, F., Merelli, M., Scarparo, C., Meyer, W., et al. (2016) · Scientific Reports · doi:10.1038/srep26860 · Cited by 26
Segireddy, M., Johnson, L. B., Szpunar, S. M., & Khatib, R. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01824.x · Cited by 27
Epidemiología de las candidiasis invasoras en población pediátrica y adulta
del Palacio, A., Villar, J., & Alhambra, A. (2009) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(09)70002-6 · Cited by 35
Purpurin Triggers Caspase-Independent Apoptosis in Candida dubliniensis Biofilms
Tsang, P. W., Wong, A. P.-K., Yang, H.-P., & Li, N.-F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0086032 · Cited by 26
“albicans is the major causative agent of candidiasis, recent epidemiological and clinical studies have shown an escalating number of bloodstream infections caused by non-albicans Candida species, which accounted for 36-63% of candidemia [8-11].”
BackgroundA study on Candida biofilm growth characteristics and its susceptibility to aureobasidin A
Munusamy, K., Vadivelu, J., & Tay, S. T. (2018) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2017.07.001 · Cited by 27
Şerefhanoğlu, K., Timurkaynak, F., Can, F., Çağır, Ü., Arslan, H., & Özdemir, F. N. (2012) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2011.03.004 · Cited by 33
Darouiche, R. O. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.02.013 · Cited by 23
Papadimitriou‐Olivgeris, M., Spiliopoulou, A., Fligou, F., Manolopoulou, P., Spiliopoulou, I. T., Vrettos, T., Dodou, V., Filos, K. S., Anastassiou, E. D., Marangos, M. N., et al. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.07.012 · Cited by 26
“non-albicans isolation in ICU patients (Chow et al., 2008a; Cornistein et al., 2013; Dimopoulos et al., 2008; Holley et al., 2009; Leroy et al., 2010).”
BackgroundResultInfluentialXin, H. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.11.035 · Cited by 28
“Unfortunately, mortality of disseminated candidiasis remains unacceptably high (11-13) in spite of current antifungal therapy (14), Therefore, more effective prophylactic and therapeutic strategies are needed.”
BackgroundCurrent aspects of invasive candidiasis and aspergillosis in adult intensive care patients
Glöckner, A., & Karthaus, M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01885.x · Cited by 25
Ylipalosaari, P., Ala-Kokko, T. I., Karhu, J., Koskela, M., Laurila, J., Ohtonen, P. P., & Syrjälä, H. (2012) · Critical Care · doi:10.1186/cc11307 · Cited by 29
“The risk of candidemia in those patients is more probably due to the immunosuppressive condition, which is often hard to influence by infection control methods [18].”
BackgroundCandidaemia in the non-neutropenic patient: A critique of the guidelines
Deshpande, A., Gaur, S., & Bal, A. M. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.06.005 · Cited by 26
Approach to the Febrile Patient in the ICU
Dimopoulos, G., & Falagas, M. E. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.04.001 · Cited by 23
Self-citationAn observational study on the epidemiological and mycological profile of Candidemia in ICU patients
Kotwal, A., Biswas, D., Sharma, J. P., Gupta, A., & Jindal, P. (2011) · Medical Science Monitor · doi:10.12659/msm.882053 · Cited by 23
Wen, S.-R., Yang, Z.-H., Dong, T.-X., Li, Y., Cao, Y.-K., Kuang, Y., & Li, H.-B. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.842434 · Cited by 20
Kothalawala, M., Jayaweera, J. A. A. S., Arunan, S., & Jayathilake, A. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1518-3 · Cited by 27
Recognition and prevention of nosocomial invasive fungal infections in the intensive care unit
Smith, J. A., & Kauffman, C. A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e6cf25 · Cited by 20
Wang, Y.-C., Shih, S.-M., Chen, Y., Hsiung, C. A., & Kuo, S. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037484 · Cited by 18
Hou, J., Deng, J. G., Liu, Y., Zhang, W., Wu, S., Liao, Q., Ma, Y., & Kang, M. (2022) · Antibiotics · doi:10.3390/antibiotics11060788 · Cited by 23
“albicans candidemia [11,29], insignificant differences in 7-day mortality, 30-day mortality, and in-hospital mortality were discovered among different Candida species groups in the present study (Table 2 and Figure 4).”
BackgroundResultErdem, İ., Oğuzoğlu, N., Öztürk-Engin, D., Özgültekin, A., Inan, A. S., Ceran, N., Kaya, F., Genç, İ., & Göktaş, P. (2010) · Medical Principles and Practice · doi:10.1159/000320305 · Cited by 19
“did not report any statistically significant differences in age, sex, underlying disease, surgical procedure or vital signs at admission between cases and controls either. The crude mortality rate among cases did not differ significantly by Candida species either. Some non- albicans Candida species had been associated…”
ResultJordán, I., Hernández, L., Balaguer, M., López-Castilla, J.-D., Casanueva, L. O., Schüffelmann, C., Teresa, M. A. G., Carlos, J., Anguita, P., & Aguilar, L. (2014) · PubMed · Cited by 23
Candidemia outcomes not improved with statin use
Welch, M. L., Liappis, A. P., & Kan, V. L. (2013) · Medical Mycology · doi:10.3109/13693786.2012.692490 · Cited by 16
Ece, G. T., Şamlıoğlu, P., Akkoçlu, G., Atalay, S., & Köse, Ş. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.4707 · Cited by 20
Bilal, H., Zhang, D., Shafiq, M., Khan, M. N., Chen, C., Khan, S., Wang, Q., Cai, L., Islam, R., Hu, H., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00708-23 · Cited by 24
Kautzky, S., Staudinger, T., & Presterl, E. (2014) · Wiener klinische Wochenschrift · doi:10.1007/s00508-014-0644-z · Cited by 17
van der Geest, P. J., Rijnders, B. J. A., Vonk, A. G., & Groeneveld, A. B. J. (2015) · Mycoses · doi:10.1111/myc.12450 · Cited by 17
Xin, H., Rosario-Colon, J., & EBERLE, K. E. (2023) · mSphere · doi:10.1128/msphere.00584-22 · Cited by 15
Factors Influencing Non-albicans Candidemia: A Case–Case–Control Study
Kofteridis, D. P., Valachis, A., Dimopoulou, D., Andrianaki, A. M., Christidou, A., Maraki, S., Spernovasilis, N. A., & Samonis, G. (2017) · Mycopathologia · doi:10.1007/s11046-017-0146-4 · Cited by 17
Metadata
- Authors
- Dimopoulos, G., Ntziora, F., Rachiotis, G., Armaganidis, A., & Falagas, M. E.
- Affiliations
- Alfa Institute of Biomedical Sciences (GR)
- Sotiria General Hospital (GR)
- University General Hospital Attikon (GR)
- Tufts University (US)
- Corresponding author
- Rachiotis, George
- Venue
- Anesthesia & Analgesia
- Published
- 2008-02
- Volume
- 106
- Issue
- 2
- Pages
- 523-529
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W1986442140
- Cited by
- 189
- References
- 44
- Citations by year
- 2025: 4 · 2024: 3 · 2023: 6 · 2022: 10 · 2021: 5 · 2020: 13 · 2019: 12 · 2018: 3 · 2017: 9 · 2016: 7 · 2015: 20 · 2014: 14 · 2013: 9 · 2012: 12
- FWCI
- 13.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Anesthesia & Analgesia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- Candida albicans, candidemia, critically ill patients, risk factors, glucocorticoids, central venous catheters, candiduria, Candida glabrata, Candida tropicalis, Candida parapsilosis, treatment response, mortality
- MeSH terms
- Aged, Aged, 80 and over, Candida albicans, Candidiasis, Cross Infection, Female, Glucocorticoids, Humans, Intensive Care Units, Male, Middle Aged, Prospective Studies, Risk Factors, Fungemia, Critical Illness, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.